Doctors fighting insurers with data
The Indianapolis Medical Society hopes an online database that compares one doctor's reimbursement rates against market
averages helps its members negotiate with health plans.
Health Care & Life Sciences
Articles
Chances of health reform passage soar
By pounding health insurers such as WellPoint Inc., President Obama has greatly boosted his chances of success in the eyes
of Wall Street. But to make his health reform bill reality, he might need to answer the less-than-reassuring news coming from
Massachusetts.
WellPoint may be anti-competitive, Connecticut AG says
WellPoint Inc.’s Anthem Blue Cross & Blue Shield of Connecticut may constrain competition through contracts that require
that the insurer receives hospital discounts at least as favorable as any provided to a competitor.
Eli Lilly to buy European rights to Pfizer animal products
The acquisition will benefit Elanco, Lilly’s animal health division in Greenfield, which has become increasingly important
to Lilly as it braces for patent-protection losses.
Sebelius asks insurers to justify rate hikes
Health and Human Services Secretary Kathleen Sebelius met at the White House with the CEOs of Indianapolis-based WellPoint,
Aetna, Cigna, UnitedHealth Group, as well as several state insurance commissioners.
Dow AgroSciences considered expansion elsewhere
Agricultural biotech firm hired a site-selection consultant and considered other cities around the world for its $340 million
expansion.
Dow Agro plans $340M expansion, 577 new jobs
The investment will greatly expand the company’s research and development capacity and is a major win for the Indiana
life sciences industry. Dow AgroSciences expects most of the positions to pay between $65,000 and $95,000 annually.
Ex-Lilly medical director named state health commissioner
Dr. Gregory N. Larkin, the former global medical director at Eli Lilly and Co., will replace Dr. Judy Monroe, who is leaving
to become deputy director of the Centers for Disease Control and Prevention.
Cornelius to retire as Bristol-Myers Squibb CEO
The former Guidant Corp. CEO and long-time Eli Lilly exec said he and his family will be returning to Indianapolis.
Dow Agro plans ‘major’ expansion announcement
Local Dow Chemical subsidiary expects to launch five new biotech products by 2012.
Lilly, Transition Therapeutics make diabetes deal
Drug developer Transition Therapeutics Inc. said Wednesday that it will pay $1 million to license a group of potential diabetes
drugs from Eli Lilly and Co.
IU cancer center names new director
Dr. Patrick J. Loehrer Sr. replaces Dr. Stephen D. Williams, the center’s founding director, who died of cancer in February
2009.
To attack costs, Lilly accelerates R&D
With President Barack Obama looking to squeeze a bit more revenue out of the pharmaceutical industry, the stakes just keep
getting higher for Eli Lilly and Co.’s efforts to develop drugs faster and cheaper.
Consumer group sues Anthem over policy changes
A consumer watchdog group filed a lawsuit Monday against WellPoint’s California subsidiary on behalf of policyholders, claiming
they were pushed to take coverage with fewer benefits and higher deductibles.
State health commissioner leaving for CDC
Dr. Judy Monroe, after five years as Indiana’s public health leader, will spearhead communication between federal and state
health agencies.
Lilly to shift more employees to Covance
Greenfield Labs operation expects to add 17 Eli Lilly and Co. workers after taking over staff of 264 in 2008 acquisition.
Conseco shares fall after dip in fourth-quarter profits
Carmel-based insurer swings to a profit, but earnings from operations decline.
WellPoint records subpoened in California probe
The California attorney general has demanded documents from several health insurers, including Indianapolis' WellPoint,
believing that their rate-setting and claims practices might be illegal.
Study: Hospital clout spurs higher Calif. health costs
While insurers get the blame for rising health-care costs for consumers, surging fees from hospitals and the growing dominance
of such providers may be just as responsible for driving up expenses, according to a new study examining California's
market.
Officials: Weak smoking ban hurts Indianapolis’ hospitality efforts
The ongoing smoking-ban debate is getting a new spark from convention leaders trying to light a fire under
lawmakers, who have been reluctant to approve the kind of comprehensive smoking ban that
health—and now tourism—officials say is needed here.